CancerProbe has developed a novel approach for the identification of immune biomarkers and tumour antigens in solid cancers.
CancerProbe's proprietary technology also reveals baseline immune responses that may identify the likelihood of benefit or toxicities from cancer therapies in specific patients or patient cohorts.
From the publishers of Nature, the BioPharma Dealmakers website brings together life sciences companies and individuals looking to identify and attract partners and dealmaking opportunities. It provides insights into dealmaking trends from BioPharma Dealmakers Editors, profiles from companies looking to partner, tools for networking and sharing knowledge, and the opportunity for sponsoring companies to showcase their expertise. BioPharma Dealmakers is THE destination for partnering professionals looking to make connections and get the latest on their industry.